Search terms
Results 1 - 10 of 36 - ordered by :
Pages: 1 2 3 4

De La Torre Hernandez J., Veiga Fernandez G., Telleria M., Lee D., Larman M., Garcia Camarero T., Pino T., Blanco R., Garcia Del Blanco B., Sainz Laso F., Zueco J. AIMS Patients undergoing ...

Date : 06/05/2016 Item size : 31362 bytes

Choi S. AIMS This study was designed to investigate 6-month clinical outcomes in patients with a very low value of P2Y12 reaction units (PRU) after various antiplatelet agent medication. METHODS AND ...

Date : 06/05/2016 Item size : 31159 bytes

After having finished the training programme, the qualified trainees may take part in the National Interventional Cardiologist Certification Examination, and those who pass the exam may get ...

Date : 26/07/2013 Item size : 52380 bytes

University of Southampton, school of medicine, Southampton, United Kingdom Aims: Little is known about (i) the prevalence of antiplatelet therapy (APT) hyporesponsiveness in stent thrombosis (ST). ...

Date : 17/05/2011 Item size : 34586 bytes

Abstract Aims There is a paucity of real-world, contemporary data of practice patterns and clinical outcomes following dual-antiplatelet therapy (DAPT) in acute myocardial infarction (AMI) patients ...

European Heart Journal - Quality of Care and Clinical Outcomes, Original Article, Juan J. Russo, Shaun G. Goodman, Akshay Bagai, Jean-Pierre Déry, Mary K. Tan, Harold N. Fisher, Xiang Zhang, Yajun ...

Date : 15/10/2016 Item size : 316571 bytes

Clopidogrel replaced ticlopidine as a safer thienopyridine for P2Y12 inhibition, but does not have universal efficacy due to poor efficiency of active metabolite formation in some individuals, only ...

European Heart Journal, Editorial, Robert F. Storey

Date : 14/07/2015

Methods and results Patients (N = 1799) who had undergone placement of 1 DES for stable coronary artery disease or acute coronary syndrome were included in 58 French sites (January 2009January ...

European Heart Journal, FASTTRACK CLINICAL RESEARCH, Gérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, Jean-Louis Georges, Didier Carrie, Xavier Dreyfus, Alain Furber, Florence Leclercq, ...

Date : 21/01/2016

The field of percutaneous coronary intervention (PCI) remains extremely active, with major advances involving revascularisation strategies and techniques, adjuvant antithrombotic therapy (with a ...

European Heart Journal, CURRENT OPINION, Philippe Gabriel Steg, Patrick W. Serruys, Mohammad Abdelghani, William Wijns

Date : 21/01/2016

Abstract Aims Clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment (RI) following percutaneous coronary interventions (PCI) represents an urgent, unmet need ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Long Zhe Guo, Moo Hyun Kim, Chang Heon Shim, Sun Young Choi, Victor L. Serebruany

Date : 01/07/2016

[...]the MATCH,1 CHARISMA,2 and TRITON3 trials raise concerns with regard to the vascular efficacy (questionable, if any) and the obvious increased bleeding risks that arise from more potent ...

European Heart Journal, Serebruany, Victor L., Goto, Shinya

Date : 01/12/2008 Item size : 149864 bytes